Global Equities
Craig Thompson, chief executive of Memorial Sloan Kettering Cancer Center, resigned from the board of drugmaker Merck last week, after questions about the cancer center's ties to the pharmaceutical industry.
Craig Thompson, chief executive of Memorial Sloan Kettering Cancer Center, resigned from the board of drugmaker Merck last week, after questions about the cancer center's ties to the pharmaceutical industry.
